Direct-to-consumer laboratory testing refers to the practice of patients ordering and receiving their own laboratory test results without having to go through a healthcare provider or physician. The process involves a person selecting a laboratory test or panel online or through a mobile app, paying for it, and then providing a sample such as blood or saliva to a laboratory either by mail or at a local service center. After the sample has been processed and analysed, the results are usually made available to the consumer online or via mobile app.
Download Free Sample PDF of this Report: https://www.extrapolate.com/sample/Healthcare-Medical-Devices-Biotechnology/direct-to-consumer-laboratory-testing-market/2578
Market Overview of Direct-to-consumer (DTC) laboratory testing:-
The Global Direct-to-Consumer (DTC) Laboratory Testing Market is projected to grow from USD 3.0 billion in 2021 to USD 10.0 billion by 2030 at a CAGR of 26.0% during the forecast period. DTC laboratory testing, also known as direct access testing, allows patients to order tests directly from a laboratory without going through their doctor. These test findings can be used to track a current health state, identify an undetected medical problem, or provide information on personal health characteristics. DTC laboratory testing is a significant aspect of on-going efforts to improve people’s engagement in their healthcare, and the accuracy and accessibility of the results are critical. Professionals in the laboratory play a crucial role in this process.
DTC laboratory testing has become increasingly popular in recent years due to the convenience it offers. Consumers can choose from a range of tests, including genetic tests, hormone tests, and tests for sexually transmitted infections. The tests are marketed as a way for individuals to take control of their health and monitor their health status without having to go through the traditional healthcare system.
Driving the Growth of the Direct-to-Consumer Laboratory Testing Market:
- Mapmygenome™
- Laboratory Corporation of America® Holdings.
- Quest Diagnostics Incorporated.
- 23andMe, Inc.
- Everlywell, Inc.
- DirectLabs®
- Ancestry
- MyMedLab, Inc.
- WellnessFX
- ANY LAB TEST NOW®
- LetsGetChecked
SEGMENTATION:-
By Sample Type
- Blood
- Urine
- Saliva
- Others
By Test Type
- Genetic Testing
- Disease Risk Assessment Testing
- CBC
- Diabetes Testing
- TSH Testing
- Others
By End-user
- Hospitals
- Clinics
- Specialty Labs
Have an Inquiry? Get in Touch with us @ https://www.extrapolate.com/enquire/Healthcare-Medical-Devices-Biotechnology/direct-to-consumer-laboratory-testing-market/25781
By Region
- North America
- Europe
- Asia Pacific
- The Middle East & Africa
- South America
Why Purchase the Report?
- The report includes information such as market dynamics scenario, opportunities and challenges during the forecast period
- Identify the key regulations prevailing in the market and understand their impact on the market over the forecast period
- Regional, sub-regional, and country-level data include the demand and supply forces along with their influence on the market.
- The competitive landscape comprises a share of key players, offering products, relevant financial information, recent developments, SWOT analysis, and strategies.
- Understand the current market scenario and viability of the global market over the forecast period.
Browse Full Report@ https://www.extrapolate.com/Healthcare-Medical-Devices-Biotechnology/direct-to-consumer-laboratory-testing-market/25781
Some of the key questions answered in this report:
- What can we estimate about the anticipated growth rates and also the global Direct-to-Consumer Laboratory Testing Market industry size by 2028?
- What will happen in the coming existing and emerging markets?
- What will the market development pace of market?
- Which are the five top players in the Direct-to-Consumer Laboratory Testing Market?
- How will the Direct-to-Consumer Laboratory Testing Market change in the upcoming years?
KEY INDUSTRY DEVELOPMENTS:
In April 2019, Living DNA changed its ancestry platform to deliver more understandable findings and new capabilities. The company’s product portfolio was improved as a result of this introduction.
In February 2019, Mapmygenome™ and Lucid Diagnostics cooperated to improve cancer prevention and tailored therapy by merging genomics and pathology test services. The company’s market position was strengthened as a result of this strategic action.
TABLE OF CONTENTS-
Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. COVID-19 Impact on Direct-to-Consumer Laboratory Testing Market
Chapter 5. Global Direct-to-Consumer Laboratory Testing Market Overview, By Product, 2017 – 2030(USD Million)
———Continued
Browse Complete TOC: https://www.extrapolate.com/toc/Healthcare-Medical-Devices-Biotechnology/direct-to-consumer-laboratory-testing-market/25781
About Extrapolate
Extrapolate is a Global Market Research, Advisory and Consulting firm which works closely with Industry experts from various industries to bring the latest and most accurate research reports.
In an era of breakneck change and a low tolerance for missed or misread opportunities, businesses need astute guidance to shape markets – not merely respond to them. Extrapolate helps clients develop market perspectives that drive success.
Contact Us
Extrapolate
Phone: (+1) 888 328 2189
E-mail: [email protected]
Website: https://www.extrapolate.com
Blog: https://www.extrapolate.com/blog